In their recent study, Fumet et al. [61] showed that the HLA-E/CD94-NKG2A/2C axis influences antitumoral immunity in HRD ovarian tumors, revealing opportunities to explore and further investigate the interacting immune network in these specific tumor genotypes. The gene discussed is KLRD1; the disease is hypoparathyroidism-retardation-dysmorphism syndrome.